Live updates: FDA Advisory Committee meeting on UGN-102 for LG-IR-NMIBC
Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer
Meeting with FDA paves way for phase 3 trial of PT-112 in mCRPC
Study shows value of precision-based approaches in prostate cancer